Fairfield, Bush & Co’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,500
Closed -$16.2K 489
2023
Q4
$16.2K Buy
+1,500
New +$14.4K 0.01% 266
2023
Q3
Sell
-10,129
Closed -$101K 510
2023
Q2
$101K Buy
+10,129
New +$96.8K 0.03% 179
2022
Q3
Sell
-1,643
Closed -$17K 463
2022
Q2
$17K Buy
+1,643
New +$18K 0.01% 267

Other funds holding VTRS

Fairfield, Bush & Co's VTRS Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of Viatris (VTRS) in Q1 2024, closing a stake of 1,500 shares — an estimated $16.2K sold.

Fairfield, Bush & Co first reported a position in VTRS in Q2 2022 and held it in 3 quarters. The position peaked at $101K in Q2 2023. 1,008 funds tracked by Wall St. Rank hold VTRS as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining Viatris position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 1,500 Viatris shares in Q1 2024, an estimated $16.2K.
  • Fairfield, Bush & Co first reported a position in Viatris in Q2 2022 and held it in 3 quarters.
  • Fairfield, Bush & Co's Viatris position peaked at $101K in Q2 2023.
  • 1,008 funds tracked by Wall St. Rank held Viatris as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.